Proceedings

Notice from the
Office of the Secretary

Ontario Crest

Ontario
Securities
Commission


20 Queen St. W.
22nd Floor
Toronto, ON M5H 3S8
Commission des
valeurs mobilières
de l'Ontario
FOR IMMEDIATE RELEASE

December 12, 2017


CANNIMED THERAPEUTICS INC. and AURORA CANNABIS INC., File No. 2017-74



TORONTO – On December 12, 2017, the Commission issued a Notice of Hearing pursuant to Sections 104 and 127 of the Securities Act, RSO 1990, c S.5 to consider the Amended Application filed by CanniMed Therapeutics Inc. (“CanniMed”) dated December 11, 2017, in respect of a request for an order that the exemption created by section 2.2(3) of National Instrument 62-104 Take-Over Bids and Issuer Bids to the restrictions on purchases during a take-over bid found in section 2.2(1) of NI 62-104 shall not apply to Aurora Cannabis Inc. until (i) March 9, 2018, or (ii) if the Commission grants the relief sought in the Amended Application of the Special Committee of the Board of Directors of CanniMed, File No. 2017-73, then 105 days after the date upon which a take-over bid circular that complies with insider bid rules is delivered to CanniMed’s shareholders.

The hearing will be held on December 20, 2017 at 9:00 a.m. at 20 Queen Street West, 17th Floor, Toronto, Ontario.

A copy of the Notice of Hearing dated December 12, 2017 and the Amended Application dated December 11, 2017 are available at www.osc.gov.on.ca.

OFFICE OF THE SECRETARY
GRACE KNAKOWSKI
SECRETARY TO THE COMMISSION


- 30 -

For media inquiries:
media_inquiries@osc.gov.on.ca
For Investor Inquiries: OSC Contact Centre
416-593-8314
1-877-785-1555 (Toll Free)